NEWS
NORMAN, OKLA. — The University of Oklahoma recently named Nishanth Rodrigues as the new Chief Information Officer. Rodrigues will begin his duties on September 30.
Rodrigues brings 20 years of experience in strategic information technology (IT) leadership, administrative leadership and IT roles in health care. Recently, Rodrigues served as the CIO at Ole Miss since 2017, where he led several major IT initiatives, including the construction of a new data center to enhance research capacity and academic services. Prior to his time at Ole Miss, Rodrigues served as the Assistant Vice President and Chief Technology Officer at Michigan State University from 2015 to 2017.
Rodrigues brings affiliations and connections with the Cisco Higher Education Advisory Council, the Satisfactory Academic Progress Higher Education Research Advisory Council, and the CIO Visions Steering Committee.
He earned his Ed.D. in Education from the University of Mississippi after earning a Master of Business Administration from Michigan State University. Rodrigues earned his undergraduate degree from Davenport University with a Bachelor of Applied Science.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. OU was named the state’s highest-ranking university in U.S. News & World Report’s most recent Best Colleges list. For more information about the university, visit ou.edu.
University of Oklahoma College of Medicine Associate Professor Lee Jennings, M.D., chief of the Division of Geriatrics and Palliative Medicine in the Department of Internal Medicine, has been selected for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program, one of the nation’s top leadership fellowships in academic health care.
The University of Oklahoma community came together once again in a powerful show of generosity during its annual Giving Day, raising over $29.6 million to support causes university-wide.
Results from a Phase 3 clinical trial offer new hope for patients with advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with chemotherapy alone. Researchers at the University of Oklahoma Health Stephenson Cancer Center enrolled patients in the global trial.
